Wall Street investors rush into psychedelic drugs | The Jerusalem Post

To Wall Street, psychedelics biotechs are more teammates than rivals

Some analysts argue that, even for competitors, a big clinical trial win for Definium Therapeutics helps validate the psychedelic field and “bring it even further into the mainstream.”